Co-Pay Relief Program Provides Direct Financial Support for Two New Support Categories

Patient Advocate Foundation (PAF), a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis  of life threatening or debilitating diseases, is pleased to announce that it has received funding support for patients with non-muscle invasive bladder cancer and those being treated with hormone suppression therapy through it Co-Pay Relief Program (CPR).

PAF’s Co-Pay Relief Program provides direct financial support for pharmaceutical co-payments to insured patients, including Medicare Part D beneficiaries, who financially and medically qualify.   CPR has three entry points and handles more than 120,000 expenditure transactions per year.  Since the program’s inception in April, 2004, CPR has allocated more than $120 million dollars in patient assistance to more than 45, 800 patients nationwide, mobilizing $480 million dollars in insurance reimbursement. 

PAF CPR Hormone BladderCancer Final Announcement

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: